FMCG

Image

Europe Smoking Cessation and Nicotine De-Addiction Market – Industry Trends and Forecast to 2031

  • FMCG
  • Upcoming Report
  • Mar 2024
  • Europe
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Europe Smoking Cessation and Nicotine De-Addiction Market, By Product Type (Nicotine Replacement Therepy Products, Drug Therepy, E-Cigarettes, and Others), Treatment Type (Pharmacological, Therapies, and Others),  Form (Gum, Inhaler, Tablet, and Others), Distribution Channel (Online, and Offline), End-User (Generation Z, Millennials, Generation X and Silent Generation) – Industry Trends and Forecast to 2031.

Europe Smoking Cessation and Nicotine De-Addiction Market

Europe Smoking Cessation and Nicotine De-Addiction Market Analysis and Size

The smoking cessation and nicotine de-addiction market offers various applications, including pharmaceuticals, nicotine replacement therapies, and behavioral therapies, aiding individuals in quitting smoking. Innovations such as mobile apps for tracking progress and virtual support groups enhance efficacy. This market addresses the urgent need for effective solutions to combat nicotine addiction.

Data Bridge Market Research analyses that the Europe smoking cessation and nicotine de-addiction market was valued at USD 17.70 billion in 2023 and is expected to reach USD 107.57 billion by 2031, registering a CAGR of 25.3% during the forecast period of 2024-2031. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, import/export analysis, pricing analysis, production consumption analysis, and consumer behaviour.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2024 to 2031

Base Year

2023

Historic Years

2022 (Customizable to 2016- 2021)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Product Type (Nicotine Replacement Therepy Products, Drug Therepy, E-Cigarettes, and Others), Treatment Type (Pharmacological, Therapies, and Others),  Form (Gum, Inhaler, Tablet, and Others), Distribution Channel (Online, and Offline), End-User (Generation Z, Millennials, Generation X and Silent Generation)

Countries Covered

Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe

Market Players Covered

Cipla Inc. (India), Johnson & Johnson Services, Inc. (U.S.), Takeda Pharmaceutical Company Limited (Japan), Alkalon A/S (Denmark), 22nd Century Group, Inc. (U.S.), GSK plc. (U.K.), Imperial Brands plc (U.K.), JT International SA (Japan), BAT (U.K.), Perrigo Company plc (Ireland), Fertin Pharma (Denmark), Cambrex Corporation (U.S.), Dr. Reddy’s Laboratories Ltd. (India), Pfizer Inc. (U.S.), Strides Pharma Science Limited (India)

Market Opportunities

  • Growing Holistic Cessation Programs for Nicotine Addiction
  • Growing Health Awareness Campaigns for Smoke-Free Life

Market Definition

Smoking cessation and nicotine de-addiction involve interventions and strategies aimed at helping individuals quit smoking and overcome nicotine addiction. This encompasses medical aids, nicotine replacement therapies, behavioral counseling, and support programs. Effective cessation methods are crucial for improving public health and reducing the harmful effects of tobacco use.

Europe Smoking Cessation and Nicotine De-Addiction Market Dynamics

Drivers

  • Rapidly Evolving Social Norms Towards Quitting

Changing societal views on smoking boost demand for cessation aid. Peer pressure and workplace policies advocating smoke-free spaces strengthen cessation attempts. Stigma linked to smoking further propels individuals towards quitting. This shift in norms fosters a surge in seeking support for smoking cessation, reflecting a broader cultural trend towards healthier lifestyles.

  • Government Regulations for Smoking Cessation Products

Government regulations worldwide, such as tobacco taxes, advertising bans, and smoke-free policies, drive demand for smoking cessation products by incentivizing smokers to quit. These stringent policies create a conducive environment for individuals to seek cessation support, contributing to the growth of the smoking cessation and nicotine de-addiction market.

Opportunities

  • Growing Holistic Cessation Programs for Nicotine Addiction

Understanding the psychological and behavioral dimensions of nicotine addiction drives the demand for holistic cessation programs. Counseling, support groups, and digital platforms provide personalized coaching and behavioral therapy, complementing pharmacological treatments. This integrated approach enhances long-term success rates in quitting smoking by addressing underlying psychological factors effectively.

  • Growing Health Awareness Campaigns for Smoke-Free Life

Public health campaigns raise awareness of smoking's health risks such as cancer and heart disease, urging individuals to quit. Highlighting benefits of cessation, these initiatives encourage seeking treatments. Through educating on the dangers and advantages of quitting, they play a pivotal role in motivating smokers to take steps towards a smoke-free life, fostering healthier communities.

Restraints/Challenges

  • Dual Use of Tobacco and Electronic Cigarettes

The dual use of electronic cigarettes alongside traditional cigarettes poses a challenge to the smoking cessation market. While some view e-cigarettes as a cessation aid, they can perpetuate nicotine addiction, hindering efforts to quit altogether. This behavior prolongs dependence on nicotine, reducing the demand for traditional cessation products and impacting the market's growth.

  •  High Relapse Rates in Smoking Cessation

The persistent issue of high relapse rates in smoking cessation presents a formidable obstacle for the market. Existing interventions fall short in delivering lasting outcomes, undermining consumer contentment and hindering the expansion and durability of the smoking cessation and nicotine de-addiction market.

This Europe smoking cessation and nicotine de-addiction market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Europe smoking cessation and nicotine de-addiction market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In March 2021, Pfizer Inc. expanded its business by developing a supplemental New Drug Application for anaplastic lymphoma kinase treatment. This diversification could boost revenue and indirectly contribute to smoking cessation efforts by strengthening the company's overall financial position
  • In March 2021, Takeda Pharmaceutical Company Limited acquired Maverick Therapeutics, enhancing its tumor therapy and T cell development portfolio. This strategic move support smoking cessation initiatives by bolstering Takeda's resources and potentially funding research in the field
  • In February 2020, Strides Pharma Science Limited, via its subsidiary Strides Consumer Private Limited, entered the market with two over-the-counter products for smoking cessation and joint pain relief. This expansion aligns with addressing health concerns, potentially providing accessible solutions for individuals seeking to quit smoking

Europe Smoking Cessation and Nicotine De-Addiction Market Scope

The Europe smoking cessation and nicotine de-addiction market is segmented on the basis of product type, treatment type, form, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

  • Nicotine Replacement Therepy Products
    • Over-the-Counter
    •  Prescription
  • Drug Therepy
    • Varenicline
    • Zyban
  • E-Cigarettes
    • Modular
    • Disposable
    • Rechargeable
  • Others
    • With Nicotine
    • Without Nicotine

 Treatment Type

  • Pharmacological
  • Therapies
  • Others

  Form

  • Gum
  • Inhaler
  • Tablet
  • Others

 Distribution Channel

  • Online
  • Offline
    • Hospital Pharmacies
    •  Drug stores
    •  Retail Pharmacies

 End-User

  • Generation Z
  • Millennials
  • Generation X
  • Silent Generation

Europe Smoking Cessation and Nicotine De-Addiction Market Regional Analysis/Insights

The Europe smoking cessation and nicotine de-addiction market is analyzed and market size insights and trends are provided by product type, treatment type, form, distribution channel and end-user as referenced above.

The countries covered in the Europe smoking cessation and nicotine de-addiction market report are Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe.

The U.K. dominates the Europe smoking cessation and nicotine de-addiction market, leveraging high innovations and product development. This fosters a substantial customer base. The demand for nicotine-containing products is rising due to an increased preference for nicotine-free alternatives.

In Germany, the demand for nicotine-containing products is on the rise, driven by increased production alongside a growing preference for nicotine-free alternatives.

France experiences a growing demand for nicotine-containing products due to heightened awareness among the population, spurred by the rising incidence of smoking-related diseases.

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Europe Smoking Cessation and Nicotine De-Addiction Market Share Analysis

The Europe smoking cessation and nicotine de-addiction market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Europe smoking cessation and nicotine de-addiction market.

Some of the major players operating in the Europe smoking cessation and nicotine de-addiction market are:

  • Cipla Inc. (India)
  • Johnson & Johnson Services, Inc. (U.S.)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Alkalon A/S (Denmark)
  • 22nd Century Group, Inc. (U.S.)
  • GSK plc. (U.K.)
  • Imperial Brands plc (U.K.)
  • JT International SA (Japan)
  • BAT (U.K.)
  • Perrigo Company plc (Ireland)
  • Fertin Pharma (Denmark)
  • Cambrex Corporation (U.S.)
  • Dr. Reddy’s Laboratories Ltd. (India)
  • Pfizer Inc. (U.S.)
  • Strides Pharma Science Limited (India)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Europe Smoking Cessation and Nicotine De-Addiction Market size will be worth USD 107.57 billion by 2031 during the forecast period.
The Europe Smoking Cessation and Nicotine De-Addiction Market growth rate is 25.3% during the forecast period.
The Government Regulations for Smoking Cessation Products and Rapidly Evolving Social Norms Towards Quitting are the growth drivers of the Europe Smoking Cessation and Nicotine De-Addiction Market.
The product type, treatment type, form, distribution channel, and end-user are the factors on which the Europe Smoking Cessation and Nicotine De-Addiction Market research is based.
The major companies in the Europe Smoking Cessation and Nicotine De-Addiction Market are Cipla Inc. (India), Johnson & Johnson Services, Inc. (U.S.), Takeda Pharmaceutical Company Limited (Japan), Alkalon A/S (Denmark), 22nd Century Group, Inc. (U.S.), GSK plc. (U.K.), Imperial Brands plc (U.K.), JT International SA (Japan), BAT (U.K.), Perrigo Company plc (Ireland), Fertin Pharma (Denmark), Cambrex Corporation (U.S.), Dr. Reddy’s Laboratories Ltd. (India), Pfizer Inc. (U.S.), Strides Pharma Science Limited (India).
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials